Year: 2025

Eshallgo Inc. Highlights Strong Momentum Across Global Shares; Highlights on Recent Operational Developments and Strategic U.S. Expansion

Written by Customer Service on November 17, 2025. Posted in Public Companies.

New York, Nov. 17, 2025 (GLOBE NEWSWIRE) — Shanghai, November 17, 2025 – Eshallgo Inc. (“Eshallgo” or the “Company”) (Nasdaq: EHGO), a leading provider of integrated office and enterprise technology along with a suite of AI intelligence solutions in China, today shared an update highlighting key operational developments and milestones over the past six months, as the Company continues to broaden its commercial capabilities in both domestic and international markets. Six Months of Operational ProgressOver the past half-year, Eshallgo has undertaken several initiatives intended to support its long-term strategic objectives. Recent developments include:Strategic Partnerships:The Company entered into exclusive partnerships with MAXSUN and Photonetco, which are expected to enhance access to additional distribution...

Rackspace Technology Appoints Lata Varghese and Phani Kishore Burre to Senior Leadership Roles Driving Cloud and AI Transformation

Written by Customer Service on November 17, 2025. Posted in Public Companies.

Strategic leadership additions position company to unlock growth and speed customer success SAN ANTONIO, Nov. 17, 2025 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid, multicloud, and AI solutions company, today announced the appointment of Lata Varghese as Senior Vice President of Business Transformation and Phani Kishore Burre, as Senior Vice President of Services and Delivery for the Public Cloud business unit. Lata Varghese brings extensive leadership experience in technology services, CXO advisory and business transformation. At Cognizant, she managed global P&L responsibilities and spearheaded the incubation and growth of emerging technology consulting practices. Her domain expertise spans financial services, digital banking, payments, blockchain, and digital assets. Most recently,...

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

Written by Customer Service on November 17, 2025. Posted in Public Companies.

SARASOTA, FL, Nov. 17, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has selected Allucent, a global full-service clinical research organization (CRO), to support the Company’s final preparations and planned submission of its investigational new drug application (IND) to the FDA for a Phase 1 clinical trial of its intranasal prophylactic SPC-15 as a treatment for PTSD. The Company currently expects to submit the IND in 2026 and commence its first-in-human (FIH) SPC-15 trial subsequent to FDA approval. “We believe that a partnership with Allucent, is a significant move forward in bringing our novel PTSD therapeutic to the clinic,” said Silo CEO Eric Weisblum. “With Allucent’s expertise,...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Written by Customer Service on November 17, 2025. Posted in Earnings Releases And Operating Results.

NRx has refiled its Abbreviated New Drug Application for KETAFREE™ (preservative free ketamine), received supportive correspondence from FDA, and expects Q2 2026 GDUFA date. HOPE Therapeutics is now operating three revenue-generating facilities in Florida and expects six or more by year-end providing neuroplastic drugs, transcranial magnetic stimulation, hyperbaric therapy, and digital therapeutics to treat suicidal depression and PTSD. NRx has secured operating capital anticipated to be sufficient for drug development operations through July 2026. The Company additionally expects to increase revenue from clinical operations. NRx received FDA grant of Fast Track Designation for NRX-100 in the treatment of suicidal ideation in patients with depression, including bipolar depression. New Real-World Data support the effect of D-cycloserine...

Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

Written by Customer Service on November 17, 2025. Posted in Public Companies.

Vancouver, Canada, Nov. 17, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the filing of an Israeli patent application for its innovative combination therapy of 5-methoxy-2-aminoindane (MEAI) and N-Acylethanolamines, such as Palmitoylethanolamide (PEA), addressing depression. The patent application stems from Clearmind’s collaboration with Neurothera Labs Inc. (TSXV: NTLX) (“Neurothera”), a subsidiary of SciSparc Ltd. (Nasdaq: SPRC). This therapy targets depression treatment using the combination of MEAI and PEA. According to the World Health Organization, major depressive disorder affects...

Atlantic International Corp. Achieves Strong YTD Performance Through Operational Efficiencies and Substantial Revenue Growth

Written by Customer Service on November 17, 2025. Posted in Earnings Releases And Operating Results.

ENGLEWOOD CLIFFS, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) — Atlantic International Corp. today announced continued operational momentum in its third-quarter 2025 results, reflecting a meaningful shift in the company’s financial trajectory and a significant improvement in year-to-date performance. For the first nine months of 2025, the company achieved $315.8 million in service revenue, supported by a record quarter that delivered $110.1 million in revenue, a 2.2% increase over the same period last year. This steady growth reflects sustained demand across a highly satisfied and referenceable client base. Atlantic International’s financial turnaround is most evident in its bottom-line results. The company narrowed its nine-month net loss to $32.3 million, or $0.59 per share, compared to $66.8 million, or $2.04 per share,...

Codere Online Reports Financial Results for the Third Quarter 2025

Written by Customer Service on November 17, 2025. Posted in Earnings Releases And Operating Results.

Total revenue was €47.7 mm in Q3 2025, while net gaming revenue1 was €51.6 mm in the period, flat versus Q3 2024 (3% in constant currency terms). Mexico revenue was €24.0 mm in Q3 2025, while net gaming revenue was €26.8 mm in the period, flat versus Q3 2024 (5% in constant currency terms). Net loss was €1.7 mm in 9M 2025 versus a net loss of €3.0 mm in 9M 2024. Total cash position of €48.3 mm as of September 30, 2025. Reiterating 2025 net gaming revenue outlook of €220-230 million and Adj. EBITDA2 outlook of €10-15 million. Repurchased $1.7 million of the Company’s shares through November 14, 2025, under the Company’s (recently upsized to) $7.5 million share buyback plan.Madrid, Spain and Tel Aviv, Israel, November 17, 2025 – (GLOBE NEWSWIRE) Codere Online (Nasdaq: CDRO / CDROW, the “Company”), a leading online gaming operator in Spain...

OneMedNet Reports 815% Bookings Increase and 4.5X increase in Inbound Demand

Written by Customer Service on November 17, 2025. Posted in Earnings Releases And Operating Results.

MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announced its financial results for the third quarter ended September 30, 2025 and operational highlights. Third Quarter Financial HighlightsBookings: $1.1M in third quarter 2025 bookings, an 815% increase compared to third quarter of 2024. Private Placements: Successfully completed an additional $0.5M private placement of common stock from an insider, providing further investment towards strategic objectives. Further Improved Balance Sheet: Continuing with its efforts first reported at the end of the second quarter, OneMedNet further improved its balance sheet by reducing total liabilities by an additional $1.9 million during the third quarter, with...

Treasure Global Reports First Quarter Year 2026 Financial Results

Written by Customer Service on November 17, 2025. Posted in Earnings Releases And Operating Results.

Strengthens Cash Position Five-Fold Amid Strategic Digital Expansion KUALA LUMPUR, Malaysia, Nov. 17, 2025 (GLOBE NEWSWIRE) — Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company, today announced its financial results for the first quarter ended September 30, 2025, highlighting a significant increase in liquidity and continued strategic investments in high-potential digital growth initiatives. Key Financial HighlightsSignificant Increase in Cash Position – As of September 30, 2025, Treasure Global held USD 1.25 million in cash and cash equivalents, up from USD 236,895 as of June 30, 2025, representing a more than five-fold increase quarter-over-quarter. This strengthened liquidity provides the Company with enhanced financial flexibility to accelerate execution,...

Terra Innovatum Global Reports Third Quarter 2025 Financial Results

Written by Customer Service on November 17, 2025. Posted in Earnings Releases And Operating Results.

Generated $131 million from the successful business combination with GSR III Acquisition Corp. and related equity financing on October 9, 2025 Sufficient capital to license, construct, build and operate the first-of-a-kind (“FOAK”) SOLOTM micro-modular reactor by 2027 and strengthen supply chain and accelerate scale-up Third party component and fuel supply chain partners secured in the U.S., Europe, and South America for the production of FOAK SOLO by 2027 First deployment site selected in Illinois, including an MOU for up to 50 commercial SOLO units to be deployed Total commercial commitments of 100 SOLO units under non-binding MOUs, reinforcing growing market demand and early-stage adoption across key global sectorsNEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — Terra Innovatum Global N.V. (“Terra Innovatum” or the...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals